Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (1967)	6/27/1998 11:53:00 PM
From: Prospector	Read Replies (1) \| Respond to of 5402

Hi Andrew .. MO, approval IS unlikely, which is simply evidenced by the fact that companies have spent billions of dollars over many years attempting to bring a blood substitute to market and have failed to do so. Why should we believe this little OTCBB company is likely to do so. That is a reasonable Opinion Andrew.. After Talking to Dr Drees & you really should give him a call.. He told me the first generation was approved by FDA... but what really got me Andrew,,, Is he said to me... " Prospector this PHER-02 really works..." I'm sold Prospector